| Drug Name | (LEMTRADA (ALEMTUZUMAB |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
patient guide
|
| Specialty (Theraputic area) |
Neurology
|
| Risk |
Safety information about risks of Autoimmune hepatitis, Haemophagocytic lymphohistiocytosis and serious cardiovascular reaction |
| patient guide |
|
| Health care provider guide |
|
| Dear Healthcare provider letter DHPC |
|
| Healthcare provider checklist |
|